Urothelial carcinoma of the bladder and the upper tract: disparate twins.
about
Upper urinary tract disease: what we know today and unmet needsWhy are upper tract urothelial carcinoma two different diseases?Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literatureEpidemiology of urothelial carcinoma.Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma.Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomyIncident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas.Metastatic transitional cell carcinoma presenting with skin metastasis.Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10-year population-based analysis.Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features.Negative pathology of ureteral carcinoma significantly delaying the diagnosis of the primary tumor of osteoblastic metastases: A case report and review of the literatureContemporary concepts and controversies in the diagnosis and management of urothelial carcinoma.Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study.Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral ProcessDownregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis.Gender differences in incidence and outcomes of urothelial and kidney cancer.Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).Diagnostic dilemmas in patients with upper tract urothelial carcinoma.Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival.HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.The Prognostic Significance of Inflammation-Associated Blood Cell Markers in Patients with Upper Tract Urothelial Carcinoma.The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma.Building bridges in urothelial carcinoma to face common challenges.Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial CarcinoThe preoperative sarcopenia status is associated with lymphovascular invasion in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.Expression of CUL1 correlates with tumour-grade and recurrence in urothelial carcinoma.The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
P2860
Q26773671-BD479340-55CB-4E48-A00F-75AD111C0EE8Q28074161-6A29CD56-360C-4BDD-B0E3-87829AB590EAQ28076374-5D653902-AAE9-433D-A3B8-D7A364EF50E0Q30234362-AF847F50-A25D-494B-A5B6-1727193F168EQ30839472-119A0F33-D7EA-47DB-946D-F07D8D98AD00Q33829643-F3353B28-D1F9-4F65-8F2D-469B56E5A56EQ33829648-01D6820F-C37F-4E75-900E-419CC7AFA653Q34333522-4D85084A-3034-4170-B5E0-EEB01A2F4D50Q35049486-EA0D1903-579F-4482-8240-5FF7FE319964Q35198137-9B2A4363-CDA9-4334-94F3-D030AD706845Q35205137-1163F449-FEBC-4CB7-A805-B44440340E9FQ35842885-4120BCDE-A36D-4A36-B117-962064239A6CQ36557362-EE840EEF-B411-4C53-A04D-A54202245554Q36773974-B3010489-CB6F-4F1F-A2E8-6CDE84580ADFQ37288470-75CC6348-29FF-4BB1-ABA4-4BC39785149CQ37351783-52C78575-3ABB-4B53-945C-5D4619015888Q37367482-85D1CC11-2FB3-483C-BC28-7E83011B2735Q37371642-02C1B1E6-32DC-4DAF-8E16-223CB53B6088Q37514045-6B971702-34B3-43B8-A442-7E6EC78FCCBFQ37584125-08CECDD5-6BB9-4274-8721-3F89EAB1D15BQ38180522-E722B6A5-A3CB-4C30-8859-0C51B0451C0DQ38599201-AB61B63D-C17B-4E20-B07C-5DF72F48EC69Q38768462-50D642B8-BB4E-45FE-940B-D38BCC51B4D4Q38812564-3A5A53E0-0724-449E-8B26-FF2D7D10638BQ38948721-F02FDFE4-A834-494B-8E3B-FD817E58ACC5Q39037312-44060B62-7B10-4D1A-89DB-F8CD5B2E0FF1Q40440250-A987A6E3-B118-4837-ACA3-67B4C4C7510DQ40713928-EEFC69E0-C1A2-4858-80F6-64F3054A5245Q41056921-876D556B-37CB-4C44-B8D5-8CCFDE375162Q41072416-75B18A54-7E41-42D3-B78E-E44A45CF2163Q41709112-BE279745-4B33-49CF-B497-136F5DD82E3FQ42023659-B01DC388-C77C-467A-B840-BE5A22B88E8DQ42381612-3909813E-ABD4-483A-9B2C-9356F4C61B3BQ47113567-10A1449D-3FBC-4C35-9A54-BB135DA41F0CQ47206281-C51AEB37-6AF4-4C00-981D-A092AF387367Q47936737-FA8BB5F2-4477-4876-B538-AB3690D9E145Q49540562-9E11150A-9390-494A-9870-6645CE8E7DDDQ49543774-DDFFFA93-6D12-4EFF-B877-0A508FBDE3F3Q51699150-5CCE7121-BF16-48CB-94C7-F6A0EBC52333Q51815779-14913AE6-99F8-4C6C-9D93-A580F8FA4AF2
P2860
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
@en
type
label
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
@en
prefLabel
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
@en
P2093
P1476
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
@en
P2093
Arnulf Stenzl
David A Green
Douglas S Scherr
Evanguelos Xylinas
Michael Rink
Morgan Roupret
Pierre I Karakiewicz
Shahrokh F Shariat
Surena F Matin
P304
P356
10.1016/J.JURO.2012.05.079
P407
P577
2012-09-27T00:00:00Z